EV/DNG (Qlaira, BAY86-5027)
Sponsors
Bayer
Conditions
ContraceptionContraceptives, OralHeadacheOral ContraceptivePelvic Pain
Phase 3
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
CompletedNCT00778609
Start: 2008-12-31End: 2010-12-31Updated: 2016-01-14
Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects
CompletedNCT01638910
Start: 2012-06-30End: 2014-11-30Updated: 2014-12-17
Unknown Phase
Non-interventional Study on Oral Contraception Not Containing Ethinylestradiol (EE) to Assess Continuation Rates and Satisfaction
CompletedNCT01200186
Start: 2010-10-31End: 2014-10-31Updated: 2015-10-16
Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy
CompletedNCT01602770
Start: 2015-02-06End: 2017-10-31Updated: 2019-04-29
Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea
CompletedNCT01797809
Start: 2013-05-11End: 2018-05-08Updated: 2019-04-09